Feature Channels

AIDS and HIV

Filters:

  • (Press "esc" to clear)

Science

Channels:

Keywords:

Mymetics’ Promising HIV Vaccine Candidate Obtains Funding to Begin Study at Texas Biomedical Research Institute

Mymeticslogo.png

Mymetics Corporation (OTCQB: MYMX) announced today that its innovative HIV vaccine candidate will enter a new preclinical trial to confirm results obtained in a previous trial. Research is to be funded by the Bill & Melinda Gates Foundation. The study will be led by Dr. Ruth Ruprecht, Scientist & Director of the Texas Biomed AIDS Research Program.

View | Comment

Medicine

Science

Channels:

Keywords:

Surprising Diversity of Antibody Family Provides Clues for HIV Vaccine Design

burton_dennis.jpg

Scientists at The Scripps Research Institute (TSRI) have described how a single family of antibodies that broadly neutralizes different strains of HIV has evolved remarkably diverse structures to attack a vulnerable site on the virus. The findings provide clues for the design of a future HIV vaccine.

View | Comment

Life

Social and Behavioral Sciences

Channels:

Keywords:

Study Explores Drug Users’ Opinions on Genetic Testing

Published in the International Journal of Drug Policy, the study, “Perceptions of genetic testing and genomic medicine among drug users,” gauged drug users’ attitudes and understandings of genetics and genetic testing through six focus groups. The focus groups were segregated by race and ethnicity to increase participants’ comfort in talking about racial and ethnic issues. Over half of the participants (53%) reported having either HIV/AIDs or HCV, or a co-infection, and understood the potential value of genetic testing.

View | Comment

Medicine

Channels:

Keywords:

Forum in D.C on PrEP for HIV Prevention

Panel discussion on PrEP for HIV prevention and its role in the HIV epidemic

View | Comment

Medicine

Channels:

Keywords:

HIV/AIDS Experiences A “Senior Moment”

aids.jpg

According to the Centers for Disease Control and Prevention (CDC), adults ages 55 and older accounted for 19 percent of the estimated 1.1 million people living with HIV infection in the United States in 2010. Sept. 18 is National HIV/AIDS Aging and Awareness Day. Funded by a CDC research grant in collaboration with the Illinois Department of Public Health (IDPH), patients in the Loyola Emergency Department and select immediate care centers are offered a free HIV test.

View | Comment

Medicine

Channels:

Keywords:

Cats Lend a Helping Paw in the Search for Anti-HIV Drugs

Researchers at the Technion say a protein found in both the feline immunodeficiency virus (FIV) - which causes AIDS in cats - and the human immunodeficiency virus (HIV) might inspire new anti-HIV drugs.

View | Comment

Medicine

Channels:

Keywords:

Puerto Ricans Who Inject Drugs, both in the Northeast U.S. and in Puerto Rico, Among Latinos at Highest Risk of Contracting HIV

The study, “Addressing the HIV/AIDS epidemic among Puerto Rican people who inject drugs: the Need for a Multi-Region Approach,” published in the American Journal of Public Health (on-line ahead of print, September 11, 2014) described the epidemic and the availability of HIV prevention and treatment programs in areas with a high concentration of Puerto Ricans, in order to provide recommendations to reduce HIV in the population.

View | Comment

Medicine

Channels:

Keywords:

Leaky Gut — A Source of Non-AIDS Complications in HIV-Positive Patients

HIV infection is no longer a fatal condition, thanks to newer antiretroviral medications, but a phenomenon has surfaced among these patients — non-AIDS complications. Case Western Reserve University School of Medicine scientists have resolved the mystery, discovering the leaky gut as the offender.

View | Comment

Medicine

Channels:

Keywords:

HIV Lessons From the Mississippi Baby

The news in July that HIV had returned in a Mississippi toddler after a two-year treatment-free remission dashed the hopes of clinicians, HIV researchers and the public at large tantalized by the possibility of a cure. But a new commentary by two leading HIV experts at Johns Hopkins argues that despite its disappointing outcome, the Mississippi case and two other recent HIV “rebounds” in adults, have yielded critical lessons about the virus’ most perplexing — and maddening — feature: its ability to form cure-defying viral hideouts.

View | Comment

Medicine

Channels:

Keywords:

New Analysis of Old HIV Vaccines Finds Potentially Protective Immune Response

Applying the benefit of hindsight, researchers at Duke Medicine have reanalyzed the findings of two historic pediatric HIV vaccine trials with encouraging results. The vaccines had in fact triggered an antibody response -- now known to be associated with protection in adults -- that was previously unrecognized in the infants studied in the 1990s.

View | Comment